‘Actualized’ rebate investigation on multinational companies

Published: 2016-10-10 11:13:34

Updated: 2016-10-10 11:13:34

The industry is paying attention to the Novartis’ rebate crisis since it might be extended to investigations on other multinational pharmaceutical companies.

It was observed the authorities of the Ministry of Health and Welfare has started to make serious discussions about the issue with the National Assembly.

According to the people concerned to the National Assembly and the government, the ...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.